Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Director departure
Quarterly results

NeuBase Therapeutics, Inc. (OHRP) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/04/2023 4 Stephan Dietrich A (Founder and CEO) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Exercised 93,234 options to buy @ $0.022, valued at $2.1k
03/17/2023 4 Branning Todd P. (CFO) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 54,200 shares @ $0
03/17/2023 4 Stephan Dietrich A (CEO and Director) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 153,000 shares @ $0
11/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/12/2022 4 RICHMAN ERIC I (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 37,600 options to buy @ $0.6, valued at $22.6k
09/12/2022 4 PRENDERGAST FRANKLYN G (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 37,600 options to buy @ $0.6, valued at $22.6k
09/12/2022 4 McDougall Gerald J (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 37,600 options to buy @ $0.6, valued at $22.6k
09/12/2022 4 GOLDSTEIN DOV A MD (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 37,600 options to buy @ $0.6, valued at $22.6k
09/12/2022 4 Ende Eric J (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 37,600 options to buy @ $0.6, valued at $22.6k
04/01/2022 4 Mann William Roland (COO) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Bought 6,200 shares @ $1.92, valued at $11.9k
03/21/2022 4 Branning Todd P. (CFO) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Bought 10,000 shares @ $1.81, valued at $18.1k
03/18/2022 4 Branning Todd P. (CFO) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Bought 10,000 shares @ $1.62, valued at $16.2k
Bought 10,000 shares @ $1.74, valued at $17.4k
03/07/2022 4 RICHMAN ERIC I (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Bought 1,580 shares @ $1.58, valued at $2.5k
Bought 1,300 shares @ $1.72, valued at $2.2k
Bought 1,000 shares @ $1.62, valued at $1.6k
01/25/2022 4 Mann William Roland (COO) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 60,180 options to buy @ $1.58, valued at $95.1k
01/25/2022 4 Rojas-Caro Sandra (Chief Medical Officer) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 44,592 options to buy @ $1.58, valued at $70.5k
01/25/2022 4 Stephan Dietrich A (President and CEO) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 306,000 options to buy @ $1.58, valued at $483.5k
01/10/2022 4 Branning Todd P. (CFO) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 300,000 options to buy @ $2.52, valued at $756k
01/10/2022 3 Branning Todd P. (CFO) has filed a Form 3 on NeuBase Therapeutics, Inc.
01/05/2022 4 Stephan Dietrich A (President and CEO) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Exercised 42,250 options to buy @ $0.001, valued at $42.3
01/05/2022 4 Ende Eric J (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 165,803 options to buy @ $2.95, valued at $489.1k
01/05/2022 3 Ende Eric J (Director) has filed a Form 3 on NeuBase Therapeutics, Inc.
09/24/2021 4 Mann William Roland (COO) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $3.49, valued at $87.3k
09/17/2021 4 McDougall Gerald J (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 38,135 options to buy @ $3.36, valued at $128.1k
09/17/2021 4 GOLDSTEIN DOV A MD (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 38,135 options to buy @ $3.36, valued at $128.1k
09/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/17/2021 4 RICHMAN ERIC I (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 38,135 options to buy @ $3.36, valued at $128.1k
06/21/2021 4 GOLDSTEIN DOV A MD (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Bought 8,000 shares @ $4.75, valued at $38k
05/25/2021 4 Rojas-Caro Sandra (Chief Medical Officer) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 280,000 options to buy @ $5.01, valued at $1.4M
05/25/2021 4 Motesharei Kianoush (See Remarks) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 250,000 options to buy @ $5.01, valued at $1.3M
05/25/2021 3 Rojas-Caro Sandra (Chief Medical Officer) has filed a Form 3 on NeuBase Therapeutics, Inc.
05/25/2021 3 Motesharei Kianoush (See Remarks) has filed a Form 3 on NeuBase Therapeutics, Inc.
05/13/2021 4 McDougall Gerald J (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 92,219 options to buy @ $4.91, valued at $452.8k
05/13/2021 3 McDougall Gerald J (Director) has filed a Form 3 on NeuBase Therapeutics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy